# RLI Corp: overview

RLI · NYSE · CIK 84246 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rli.md) · [Financials](/companies/rli/financials.md) · [Filings](/companies/rli/filings.md) · [Insiders](/companies/rli/insiders.md)

Latest reported revenue: [$477.0m](/filings/0001104659-26-117864.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 21, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-117864).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [439 d](/filings/0001104659-26-018013.md) | [408](/filings/0001104659-26-048474.md) | [500](/filings/0001104659-26-086576.md) | [509](/filings/0001104659-26-117864.md) | [466 d](/filings/0001104659-26-018013.md) | [424](/filings/0001104659-26-048474.md) | [576](/filings/0001104659-26-086576.md) | [477](/filings/0001104659-26-117864.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [9.3% d](/filings/0001104659-26-018013.md) | [15.5%](/filings/0001104659-26-117864.md) | [24.9%](/filings/0001104659-26-117864.md) | [24.5%](/filings/0001104659-26-117864.md) | [19.6% d](/filings/0001104659-26-018013.md) | [12.9%](/filings/0001104659-26-117864.md) | [29.2%](/filings/0001104659-26-117864.md) | [17.0%](/filings/0001104659-26-117864.md) |
| Diluted EPS | $ per share | not reported | [0.68](/filings/0001104659-26-048474.md) | [1.34](/filings/0001104659-26-086576.md) | [1.35](/filings/0001104659-26-117864.md) | not reported | [0.60](/filings/0001104659-26-048474.md) | [1.82](/filings/0001104659-26-086576.md) | [0.88](/filings/0001104659-26-117864.md) |
| Free cash flow | $m | [128 d](/filings/0001104659-26-018013.md) | [102](/filings/0001104659-26-048474.md) | [173 d](/filings/0001104659-26-086576.md) | [178 d](/filings/0001104659-26-117864.md) | [155 d](/filings/0001104659-26-018013.md) | [41.8](/filings/0001104659-26-048474.md) | [142 d](/filings/0001104659-26-086576.md) | [192 d](/filings/0001104659-26-117864.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,179](/filings/0001558370-24-001599.md) | [1,698](/filings/0001558370-25-001301.md) | [1,512](/filings/0001104659-26-018013.md) | [1,770](/filings/0001104659-26-018013.md) | [1,882](/filings/0001104659-26-018013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [23.7%](/filings/0001558370-24-001599.md) | [34.4%](/filings/0001558370-25-001301.md) | [20.1%](/filings/0001104659-26-018013.md) | [19.5%](/filings/0001104659-26-018013.md) | [21.4%](/filings/0001104659-26-018013.md) |
| Diluted EPS | $ per share | [6.11](/filings/0001558370-24-001599.md) | [6.37](/filings/0001558370-25-001301.md) | [3.31](/filings/0001104659-26-018013.md) | [3.74](/filings/0001104659-26-018013.md) | [4.37](/filings/0001104659-26-018013.md) |
| Free cash flow | $m | [377](/filings/0001558370-24-001599.md) | [245](/filings/0001558370-25-001301.md) | [458](/filings/0001104659-26-018013.md) | [556](/filings/0001104659-26-018013.md) | [609](/filings/0001104659-26-018013.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rli/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $528.3m | 8,943,750 |  | Reduced −41,682 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $492.2m | 8,332,056 |  | Added +259,818 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $398.0m | 6,737,775 |  | Reduced −266,368 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $280.6m | 4,750,995 |  | Reduced −44,201 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $244.4m | 4,137,133 |  | Added +26,190 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $214.5m | 3,631,273 |  | Added +1,051,318 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $154.4m | 2,614,068 |  | Added +120,036 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $148.8m | 2,519,527 |  | Added +1,647,494 |
| [Markel Group Inc.](/funds/1096343.md) | 2026-06-30 | $141.4m | 2,394,544 |  | Unchanged |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $139.3m | 2,358,611 |  | Added +567,390 |

## Recent filings

[All 2,060 filings](/companies/rli/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 17:10 ET | [8-K](/filings/0000084246-26-000020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000084246-26-000020 |
| 2026-10-21 | 16:43 ET | [10-Q](/filings/0001104659-26-117864.md) | Quarterly report, period 2026-09-30 | 0001104659-26-117864 |
| 2026-10-19 | 16:20 ET | [8-K](/filings/0001104659-26-116895.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-116895 |
| 2026-08-13 | 16:10 ET | [8-K](/filings/0001104659-26-095914.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-095914 |
| 2026-07-28 | 06:56 ET | [8-K](/filings/0000084246-26-000016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000084246-26-000016 |
| 2026-07-24 | 12:15 ET | [10-Q](/filings/0001104659-26-086576.md) | Quarterly report, period 2026-06-30 | 0001104659-26-086576 |
| 2026-07-22 | 16:16 ET | [8-K](/filings/0001104659-26-085815.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-085815 |
| 2026-07-15 | 16:10 ET | [8-K](/filings/0001104659-26-083885.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-083885 |
| 2026-06-25 | 16:15 ET | [8-K](/filings/0001104659-26-077770.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-077770 |
| 2026-05-20 | 16:30 ET | [8-K](/filings/0001104659-26-064543.md) | 5.07 Shareholder vote results | 0001104659-26-064543 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-018013.md), filed Feb 20, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 84246
- Tickers: RLI
- Exchange: NYSE
- SIC code: 6331 Fire, Marine & Casualty Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.